Woyach J, Tedeschi A, Munir T, Siddiqi T, et al. Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2021 Aug 13:1-5. doi: 10.1080/10428194.2021.1957871.
PMID: 34384312